Related Experiment Video

Updated: Jun 24, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Rak functions as a tumor suppressor by regulating PTEN protein stability and function

Eun-Kyoung Yim1, Guang Peng, Hui Dai

  • 1Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77054, USA.

Cancer Cell
|April 7, 2009
PubMed

Insights

Rak tyrosine kinase suppresses breast cancer by stabilizing the PTEN tumor suppressor. Loss of Rak leads to PTEN degradation, promoting cancer cell growth and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • PTEN tumor suppressor loss is common in breast cancer via unknown mechanisms.
  • Understanding PTEN regulation is crucial for breast cancer therapy.

Purpose of the Study:

  • Investigate the role of Rak tyrosine kinase in PTEN regulation.
  • Determine Rak's mechanism in controlling PTEN stability and function.
  • Evaluate Rak's potential as a tumor suppressor in breast cancer.

Main Methods:

  • Co-immunoprecipitation to assess PTEN-Rak interaction.
  • Western blotting to detect PTEN phosphorylation and ubiquitination.
  • Cell-based assays for proliferation, invasion, and colony formation.
  • In vivo tumor growth studies.
  • Mammary epithelial cell transformation assays.

Main Results:

  • Rak tyrosine kinase directly interacts with and phosphorylates PTEN at Tyr336.
  • Rak knockdown increases PTEN binding to NEDD4-1, promoting polyubiquitination and degradation.
  • Ectopic Rak expression inhibits breast cancer cell proliferation, invasion, and colony formation in vitro and tumor growth in vivo.
  • Rak knockdown induces transformation of normal mammary epithelial cells.

Conclusions:

  • Rak acts as a tumor suppressor by maintaining PTEN protein stability and function.
  • Rak's interaction with PTEN and regulation of its degradation pathway is a key mechanism.
  • Targeting the Rak-PTEN axis may offer novel therapeutic strategies for breast cancer.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...